FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology and can be used in diagnostics of eye cornea disease and injury. For the invention implementation chitosan succinate is inserted into the aqueous solution of fluorescein in the following ratio, wt % rating: fluorescein - 0.005-0.1; chitosan succinate - 1.0-1.5; distilled water - the rest.
EFFECT: use of the invention provides for formation of stable precorneal colouring membrane of prolonged action.
2 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION FOR DIAGNOSIS OF DISEASES AND TRAUMAS OF EYE CORNEA | 1995 |
|
RU2142292C1 |
PREPARATION FOR DIAGNOSING CORNEAL INJURIES AND DISEASES | 2014 |
|
RU2552318C1 |
PREPARATION FOR DIAGNOSIS OF EYE CORNEA ILLNESS AND TRAUMA | 1995 |
|
RU2098089C1 |
PREPARATION FOR EYE CORNEA ILLNESS AND TRAUMA DIAGNOSIS | 1995 |
|
RU2097031C1 |
OPHTHALMOLOGICAL MEANS FOR CORNEAL INJURIES AND DISEASES DIAGNOSTICS | 2016 |
|
RU2633083C1 |
METHOD OF DETERMINING DEGREE OF BLEPHAROCONJUNCTIVAL FORM OF DRY EYE SYNDROME | 2012 |
|
RU2500340C1 |
GEL-LIKE ARTIFICIAL TEARS WITH ANTISEPTIC AND REPARATIVE ACTION | 2018 |
|
RU2679319C1 |
THERAPY OF CORNEOCONJUNCTIVAL XEROSIS | 2008 |
|
RU2360658C1 |
METHOD OF DETERMINING THE PERMEABILITY OF CORNEA IN THE AREA OF ITS PATHOLOGICAL FOCUS WITH THE DISTURBANCE OF EPITHELIUM INTEGRITY | 0 |
|
SU1398860A1 |
OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
Authors
Dates
2010-11-27—Published
2009-06-25—Filed